Daisuke Kawakita

12PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyPredictive and prognostic markersSolid tumoursOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 06, 2026
Increased Lymphocyte Proportions as a Candidate Biomarker for Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitors and Chemotherapy.

|Apr 04, 2026
Attributable fraction and interaction of tobacco smoking and alcohol drinking on the risk of head and neck cancer: a pooled analysis of 11 prospective cohort studies in Japan.

Hiroshi Tsuge, Isao Oze, Hidemi Ito

|Dec 26, 2025
Nationwide analysis of olfactory neuroblastoma in Japan: evolving treatment approaches and prognostic outcomes.

Mariko Sekimizu, Takuya Mikoshiba, Ryoto Nagai

|Jun 04, 2025
Impact of medications on the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic head and neck cancer.

Kiyoshi Minohara, Takuma Matoba, Michi Sawabe

|Jan 27, 2025
Histological Type-Specific Behavior in Sarcomas: Analysis of Head and Neck Cancer Registry of Japan.

Kenya Kobayashi, Seiichi Yoshimoto, Koji Yamamura

|Jul 23, 2024
The clinicopathological and prognostic significance of autonomic nerves in salivary duct carcinoma.

Manami Kajiwara, Hideaki Takahashi, Masato Nakaguro

Pageof 2

Frequent Collaborators

3 joint publications

Yuichiro Tada

2 joint publications

Masato Nakaguro

2 joint publications

Toshitaka Nagao

1 joint publications

Sayuri Yamazaki